Clinical trials: latest news

Clinical trials resources

  • Clinical trials

    A clinical trial is a study in which a new treatment is assessed.There are legal requirements on how a trial should be run.If you choose to join a...

    From: Factsheets

    Information level Level 2
  • Thinking about joining a clinical trial?

    Before you make a decision about joining a clinical trial, make sure you fully understand what’s involved.There will be benefits and risks to joining any clinical trial.Discuss...

    From: Factsheets

    Information level Level 2

Clinical trials features

Clinical trials in your own words

Clinical trials news from aidsmap

More news

Clinical trials news selected from other sources

  • For cancer patients with HIV, immunotherapy appears safe

    Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials

    08 November 2017 | Fred Hutch
  • DAIDS Boss Muses on the Future of HIV Prevention Research

    Below are some of Dr. Dieffenbach’s rather intentionally provocative ideas about specific HIV prevention research candidates—challenges and promises, and the questions they may raise for the next clinical trial research network structure.

    20 October 2017 | AVAC
  • PrEP activists warn new NHS trial will fail if black gay men don't take part

    Sexual health campaigners are warning a newly launched trial in the UK will fail if not enough people of color take part, Gay Star News can reveal. The experts are estimating the overwhelming majority of the patients in the NHS trial will be white gay men. This could provide an unbalanced study with most of the evidence from just one group who could benefit from access to PrEP.

    13 October 2017 | Gay Star News
  • England PrEP Impact Trial Launches

    The England PrEP IMPACT Trial goes live tomorrow. Before you all go rushing out to your local sexual health clinic there are a few things we’d like to make you aware of. The trial team are expecting an initial surge for demand and clinics are doing their best to accommodate this. There are a few things we can do to help. Please try to wait until your regular clinic opens as part of the trial rather than register at a new clinic - though we completely understand that expecting people to wait for access to NHS PrEP is unacceptable to some. The trial team are pushing really hard for most of the 70 initial sites to be live as soon as possible with the remaining 130 clinics following quickly behind. Most clinics are expected to be up by the end of November and all by April 2018.

    11 October 2017 | I Want PrEP Now
  • PrEP presents questions for HIV prevention researchers, survey seeks answers

    In any trial of an HIV prevention measure, ethics demand that all known effective measures, which in earlier years added up to counseling and condoms, be made available. In a setting where PrEP would not otherwise be available though, is offering it sweetening the pot more than is ethically acceptable?

    04 October 2017 | Science Speaks
  • 5 things you need to know to join the IMPACT trial

    The PrEP IMPACT trial is a clinical trial in England and will operate differently to the ways you usually get sexual health services. You'll need to meet eligibility criteria to go on the trial, and you'll need to read and sign paperwork before you start. You'll also be asked to visit your trial clinic every 3 months for HIV and STI tests. The PrEP IMPACT trial starts in September 2017 – and there are 5 important sets of things you need to know if you’re thinking about joining the trial.

    07 September 2017 | PrEPster
  • Preparation meets opportunity: how 3ie’s stakeholder engagement paid off on HIV self-testing

    Initially there was scepticism about the acceptability, usability and safety of self-testing in sub-Saharan Africa. 3ie funded formative research to assess whether self-testing could get more people to test in Kenya. Then, 3ie funded three pilots and their rapid impact evaluations to determine whether offering HIV self-tests to partners of pregnant and post-partum women, and to truck drivers, could get more of them to test for HIV.

    30 August 2017 | Evidence Matters
  • PrEP impact trial questions and answers

    NHS England has announced the start of a pioneering implementation trial to provide HIV prevention drugs to people at high risk of HIV infection.

    21 August 2017 | NHS England
  • Should everyone be getting the HIV prevention pill as part of this HIV vaccine study?

    More than 500 people have signed up since December to be part of the country’s largest HIV vaccine trial, but some experts are crying foul over what they say is unequal access to the HIV prevention pill among participants.

    30 June 2017 | Bhekisisa
  • Slow start to landmark South African HIV vaccine trial

    Stringent global standards to enlist participants are slowing the process of volunteering to participate in South Africa’s ground-breaking HIV vaccine trial, known as HVTN 702.

    02 June 2017 | Medical Brief
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.